These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 19679411

  • 1. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
    Booker L, Naidu PS, Razdan RK, Mahadevan A, Lichtman AH.
    Drug Alcohol Depend; 2009 Nov 01; 105(1-2):42-7. PubMed ID: 19679411
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
    DeLong GT, Wolf CE, Poklis A, Lichtman AH.
    Drug Alcohol Depend; 2010 Nov 01; 112(1-2):126-33. PubMed ID: 20619971
    [Abstract] [Full Text] [Related]

  • 3. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM, Wakley AA, Tsutsui KT, Laggart JD.
    J Pharmacol Exp Ther; 2012 Mar 01; 340(3):787-800. PubMed ID: 22182934
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.
    Wiley JL, Marusich JA, Blough BE, Namjoshi O, Brackeen M, Akinfiresoye LR, Walker TD, Prioleau C, Barrus DG, Gamage TF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jun 08; 132():110984. PubMed ID: 38417478
    [Abstract] [Full Text] [Related]

  • 5. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    Haller VL, Cichewicz DL, Welch SP.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):60-8. PubMed ID: 16919265
    [Abstract] [Full Text] [Related]

  • 6. The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.
    Kinsey SG, Mahadevan A, Zhao B, Sun H, Naidu PS, Razdan RK, Selley DE, Imad Damaj M, Lichtman AH.
    Neuropharmacology; 2011 Sep 28; 60(2-3):244-51. PubMed ID: 20849866
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
    Fride E, Ponde D, Breuer A, Hanus L.
    Neuropharmacology; 2005 Jun 28; 48(8):1117-29. PubMed ID: 15910887
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological evaluation of aerosolized cannabinoids in mice.
    Lichtman AH, Peart J, Poklis JL, Bridgen DT, Razdan RK, Wilson DM, Poklis A, Meng Y, Byron PR, Martin BR.
    Eur J Pharmacol; 2000 Jul 07; 399(2-3):141-9. PubMed ID: 10884513
    [Abstract] [Full Text] [Related]

  • 15. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ, Crim JL, Darmani NA.
    Pharmacol Biochem Behav; 2002 Jul 07; 71(1-2):155-62. PubMed ID: 11812518
    [Abstract] [Full Text] [Related]

  • 16. The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.
    Raborn ES, Marciano-Cabral F, Buckley NE, Martin BR, Cabral GA.
    J Neuroimmune Pharmacol; 2008 Jun 07; 3(2):117-29. PubMed ID: 18247131
    [Abstract] [Full Text] [Related]

  • 17. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
    Pertwee RG, Thomas A, Stevenson LA, Ross RA, Varvel SA, Lichtman AH, Martin BR, Razdan RK.
    Br J Pharmacol; 2007 Mar 07; 150(5):586-94. PubMed ID: 17245367
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.
    McMahon LR.
    Br J Pharmacol; 2011 Mar 07; 162(5):1060-73. PubMed ID: 21091643
    [Abstract] [Full Text] [Related]

  • 20. Cannabimimetic properties of ajulemic acid.
    Vann RE, Cook CD, Martin BR, Wiley JL.
    J Pharmacol Exp Ther; 2007 Feb 07; 320(2):678-86. PubMed ID: 17105826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.